Form 8-K - Current report:
SEC Accession No. 0001641172-25-012336
Filing Date
2025-05-23
Accepted
2025-05-23 17:27:00
Documents
15
Period of Report
2025-05-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 53749
2 EX-10.1 ex10-1.htm EX-10.1 51042
3 EX-10.2 ex10-2.htm EX-10.2 54276
4 EX-10.3 ex10-3.htm EX-10.3 54943
  Complete submission text file 0001641172-25-012336.txt   419857

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE mgrx-20250522.xsd EX-101.SCH 3032
6 XBRL LABEL FILE mgrx-20250522_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE mgrx-20250522_pre.xml EX-101.PRE 22370
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3848
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 25983542
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)